Terns Pharmaceuticals Inc (TERN)

6.63 -0.16 (-2.36%) USD  |  NASDAQ  |  Nov 14, 11:05
More

Terns Pharmaceuticals Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2021. Upgrade now.
Date Value
December 31, 2021 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

Upgrade
Minimum
2021
Upgrade
Maximum
2021
Upgrade
Average
Upgrade
Median
2021

Research and Development Expense (% of Annual Revenues) Benchmarks

Eli Lilly and Co Upgrade
Viking Therapeutics Inc --
Biomarin Pharmaceutical Inc Upgrade
Elite Pharmaceuticals Inc Upgrade
Verrica Pharmaceuticals Inc Upgrade